APO Research
Talk to an analyst

APO RESEARCH · REPORT

Intravenous Immunoglobulin(IVIg) Therapy

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Intravenous Immunoglobulin(IVIg) Therapy Industry Growth and Trends Forecast to 2032

29 December 2025127 pages

Choose your research edition.

Industry ResearchIntravenous Immunoglobulin(IVIg) Therapy Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Intravenous Immunoglobulin(IVIg) Therapy Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Intravenous Immunoglobulin(IVIg) Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intravenous Immunoglobulin(IVIg) Therapy Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Intravenous Immunoglobulin(IVIg) Therapy Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Intravenous Immunoglobulin(IVIg) Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Intravenous Immunoglobulin(IVIg) Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Intravenous Immunoglobulin(IVIg) Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Intravenous Immunoglobulin(IVIg) Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Intravenous Immunoglobulin(IVIg) Therapy include TEIJIN LIMITED, Baxter, Biotest, Boya-Bio, CNBG, CSL Plasma, Grifols, Kamada and Kedrion, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Intravenous Immunoglobulin(IVIg) Therapy market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Intravenous Immunoglobulin(IVIg) Therapy market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Intravenous Immunoglobulin(IVIg) Therapy market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Intravenous Immunoglobulin(IVIg) Therapy.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Intravenous Immunoglobulin(IVIg) Therapy market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Intravenous Immunoglobulin(IVIg) Therapy Market by Company

TEIJIN LIMITED

Baxter

Biotest

Boya-Bio

CNBG

CSL Plasma

Grifols

Kamada

Kedrion

LFB Group

Nanyue Biopharming

Octapharma

Sinopharm

Beijing Tiantan Biological Products

Guangdong Shuagnlin Bio-pharmacy

Hualan Bio

Shanghai RAAS

Weiguang Biological

Taibang Biologic Group

Takeda

Intravenous Immunoglobulin(IVIg) Therapy Segment by Type

5g/100ml

2.5g/50ml

1g/20ml

10g/200ml

1.25g/25ml

Others

Intravenous Immunoglobulin(IVIg) Therapy Segment by Application

Autoimmune Disease

Immunodeficiency

Acute Infection

Others

Intravenous Immunoglobulin(IVIg) Therapy Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Immunoglobulin(IVIg) Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intravenous Immunoglobulin(IVIg) Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Immunoglobulin(IVIg) Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Intravenous Immunoglobulin(IVIg) Therapy manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Intravenous Immunoglobulin(IVIg) Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 5g/100ml Table 2. Major Company of 2.5g/50ml Table 3. Major Company of 1g/20ml Table 4. Major Company of 10g/200ml Table 5. Major Company of 1.25g/25ml Table 6. Major Company of Others Table 7. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2026) & (K Units) Table 9. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share in Volume by Type (2021-2026) Table 10. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2026) & (US$ Million) Table 11. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share in Value by Type (2021-2026) Table 12. Global Intravenous Immunoglobulin(IVIg) Therapy Price by Type (2021-2026) & (US$/Unit) Table 13. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2027-2032) & (K Units) Table 14. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share in Volume by Type (2027-2032) Table 15. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2027-2032) & (US$ Million) Table 16. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share in Value by Type (2027-2032) Table 17. Global Intravenous Immunoglobulin(IVIg) Therapy Price by Type (2027-2032) & (US$/Unit) Table 18. North America Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2026) & (K Units) Table 19. North America Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2026) & (K Units) Table 21. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2026) & (K Units) Table 23. Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2026) & (K Units) Table 25. Latin America Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2026) & (K Units) Table 27. Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2021-2026) & (US$ Million) Table 28. Intravenous Immunoglobulin(IVIg) Therapy Industry Trends Table 29. Intravenous Immunoglobulin(IVIg) Therapy Industry Drivers Table 30. Intravenous Immunoglobulin(IVIg) Therapy Industry Opportunities and Challenges Table 31. Intravenous Immunoglobulin(IVIg) Therapy Industry Restraints Table 32. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Company (2021-2026) Table 34. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Company (2021-2026) & (K Units) Table 35. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Share by Company (2021-2026) Table 36. Global Intravenous Immunoglobulin(IVIg) Therapy Market Price by Company (2021-2026) & (US$/Unit) Table 37. Global Intravenous Immunoglobulin(IVIg) Therapy Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Intravenous Immunoglobulin(IVIg) Therapy Major Company Production Sites and Headquarters Table 39. Global Intravenous Immunoglobulin(IVIg) Therapy Company, Product Type & Application Table 40. Global Intravenous Immunoglobulin(IVIg) Therapy Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Intravenous Immunoglobulin(IVIg) Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Intravenous Immunoglobulin(IVIg) Therapy Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Region (2021-2026) & (K Units) Table 45. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share in Volume by Region (2021-2026) Table 46. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Region (2021-2026) & (US$ Million) Table 47. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share in Value by Region (2021-2026) Table 48. Global Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Region (2027-2032) & (K Units) Table 50. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share in Volume by Region (2027-2032) Table 51. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Region (2027-2032) & (US$ Million) Table 52. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share in Value by Region (2027-2032) Table 53. Global Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 54. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2026) & (K Units) Table 56. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share in Volume by Application (2021-2026) Table 57. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2026) & (US$ Million) Table 58. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share in Value by Application (2021-2026) Table 59. Global Intravenous Immunoglobulin(IVIg) Therapy Price by Application (2021-2026) & (US$/Unit) Table 60. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2027-2032) & (K Units) Table 61. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share in Volume by Application (2027-2032) Table 62. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2027-2032) & (US$ Million) Table 63. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share in Value by Application (2027-2032) Table 64. Global Intravenous Immunoglobulin(IVIg) Therapy Price by Application (2027-2032) & (US$/Unit) Table 65. North America Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2026) & (K Units) Table 66. North America Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2026) & (K Units) Table 68. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2026) & (K Units) Table 70. Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2026) & (K Units) Table 72. Latin America Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2026) & (K Units) Table 74. Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2021-2026) & (US$ Million) Table 75. TEIJIN LIMITED Company Information Table 76. TEIJIN LIMITED Business Overview Table 77. TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 79. TEIJIN LIMITED Recent Development Table 80. Baxter Company Information Table 81. Baxter Business Overview Table 82. Baxter Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Baxter Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 84. Baxter Recent Development Table 85. Biotest Company Information Table 86. Biotest Business Overview Table 87. Biotest Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Biotest Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 89. Biotest Recent Development Table 90. Boya-Bio Company Information Table 91. Boya-Bio Business Overview Table 92. Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 94. Boya-Bio Recent Development Table 95. CNBG Company Information Table 96. CNBG Business Overview Table 97. CNBG Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. CNBG Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 99. CNBG Recent Development Table 100. CSL Plasma Company Information Table 101. CSL Plasma Business Overview Table 102. CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 104. CSL Plasma Recent Development Table 105. Grifols Company Information Table 106. Grifols Business Overview Table 107. Grifols Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Grifols Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 109. Grifols Recent Development Table 110. Kamada Company Information Table 111. Kamada Business Overview Table 112. Kamada Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Kamada Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 114. Kamada Recent Development Table 115. Kedrion Company Information Table 116. Kedrion Business Overview Table 117. Kedrion Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Kedrion Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 119. Kedrion Recent Development Table 120. LFB Group Company Information Table 121. LFB Group Business Overview Table 122. LFB Group Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. LFB Group Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 124. LFB Group Recent Development Table 125. Nanyue Biopharming Company Information Table 126. Nanyue Biopharming Business Overview Table 127. Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 129. Nanyue Biopharming Recent Development Table 130. Octapharma Company Information Table 131. Octapharma Business Overview Table 132. Octapharma Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Octapharma Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 134. Octapharma Recent Development Table 135. Sinopharm Company Information Table 136. Sinopharm Business Overview Table 137. Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 139. Sinopharm Recent Development Table 140. Beijing Tiantan Biological Products Company Information Table 141. Beijing Tiantan Biological Products Business Overview Table 142. Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 143. Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 144. Beijing Tiantan Biological Products Recent Development Table 145. Guangdong Shuagnlin Bio-pharmacy Company Information Table 146. Guangdong Shuagnlin Bio-pharmacy Business Overview Table 147. Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 148. Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 149. Guangdong Shuagnlin Bio-pharmacy Recent Development Table 150. Hualan Bio Company Information Table 151. Hualan Bio Business Overview Table 152. Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 153. Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 154. Hualan Bio Recent Development Table 155. Shanghai RAAS Company Information Table 156. Shanghai RAAS Business Overview Table 157. Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 158. Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 159. Shanghai RAAS Recent Development Table 160. Weiguang Biological Company Information Table 161. Weiguang Biological Business Overview Table 162. Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 163. Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 164. Weiguang Biological Recent Development Table 165. Taibang Biologic Group Company Information Table 166. Taibang Biologic Group Business Overview Table 167. Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 168. Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 169. Taibang Biologic Group Recent Development Table 170. Takeda Company Information Table 171. Takeda Business Overview Table 172. Takeda Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 173. Takeda Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio Table 174. Takeda Recent Development Table 175. North America Intravenous Immunoglobulin(IVIg) Therapy Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 176. North America Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2021-2026) & (K Units) Table 177. North America Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country (2021-2026) Table 178. North America Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Country (2027-2032) & (K Units) Table 179. North America Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share Forecast by Country (2027-2032) Table 180. North America Intravenous Immunoglobulin(IVIg) Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 181. North America Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country (2021-2026) & (US$ Million) Table 182. North America Intravenous Immunoglobulin(IVIg) Therapy Market Share by Country (2021-2026) Table 183. North America Intravenous Immunoglobulin(IVIg) Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 184. North America Intravenous Immunoglobulin(IVIg) Therapy Market Share Forecast by Country (2027-2032) Table 185. Europe Intravenous Immunoglobulin(IVIg) Therapy Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 186. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2021-2026) & (K Units) Table 187. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country (2021-2026) Table 188. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Country (2027-2032) & (K Units) Table 189. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share Forecast by Country (2027-2032) Table 190. Europe Intravenous Immunoglobulin(IVIg) Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 191. Europe Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country (2021-2026) & (US$ Million) Table 192. Europe Intravenous Immunoglobulin(IVIg) Therapy Market Share by Country (2021-2026) Table 193. Europe Intravenous Immunoglobulin(IVIg) Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 194. Europe Intravenous Immunoglobulin(IVIg) Therapy Market Share Forecast by Country (2027-2032) Table 195. Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 196. Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2021-2026) & (K Units) Table 197. Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country (2021-2026) Table 198. Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Country (2027-2032) & (K Units) Table 199. Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share Forecast by Country (2027-2032) Table 200. Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 201. Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country (2021-2026) & (US$ Million) Table 202. Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Market Share by Country (2021-2026) Table 203. Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 204. Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Market Share Forecast by Country (2027-2032) Table 205. Latin America Intravenous Immunoglobulin(IVIg) Therapy Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 206. Latin America Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2021-2026) & (K Units) Table 207. Latin America Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country (2021-2026) Table 208. Latin America Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Country (2027-2032) & (K Units) Table 209. Latin America Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share Forecast by Country (2027-2032) Table 210. Latin America Intravenous Immunoglobulin(IVIg) Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 211. Latin America Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country (2021-2026) & (US$ Million) Table 212. Latin America Intravenous Immunoglobulin(IVIg) Therapy Market Share by Country (2021-2026) Table 213. Latin America Intravenous Immunoglobulin(IVIg) Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 214. Latin America Intravenous Immunoglobulin(IVIg) Therapy Market Share Forecast by Country (2027-2032) Table 215. Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 216. Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2021-2026) & (K Units) Table 217. Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country (2021-2026) Table 218. Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Country (2027-2032) & (K Units) Table 219. Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share Forecast by Country (2027-2032) Table 220. Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 221. Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country (2021-2026) & (US$ Million) Table 222. Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Market Share by Country (2021-2026) Table 223. Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 224. Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Market Share Forecast by Country (2027-2032) Table 225. Key Raw Materials Table 226. Raw Materials Key Suppliers Table 227. Intravenous Immunoglobulin(IVIg) Therapy Distributors List Table 228. Intravenous Immunoglobulin(IVIg) Therapy Customers List Table 229. Research Programs/Design for This Report Table 230. Authors List of This Report Table 231. Secondary Sources Table 232. Primary Sources List of Figures Figure 1. Intravenous Immunoglobulin(IVIg) Therapy Image Figure 2. Global Intravenous Immunoglobulin(IVIg) Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intravenous Immunoglobulin(IVIg) Therapy Market Size (2021-2032) & (US$ Million) Figure 4. Global Intravenous Immunoglobulin(IVIg) Therapy Sales (2021-2032) & (K Units) Figure 5. 5g/100ml Image Figure 6. Global 5g/100ml Sales YoY Growth (2021-2032) & (K Units) Figure 7. 2.5g/50ml Image Figure 8. Global 2.5g/50ml Sales YoY Growth (2021-2032) & (K Units) Figure 9. 1g/20ml Image Figure 10. Global 1g/20ml Sales YoY Growth (2021-2032) & (K Units) Figure 11. 10g/200ml Image Figure 12. Global 10g/200ml Sales YoY Growth (2021-2032) & (K Units) Figure 13. 1.25g/25ml Image Figure 14. Global 1.25g/25ml Sales YoY Growth (2021-2032) & (K Units) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 17. Global Intravenous Immunoglobulin(IVIg) Therapy Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Intravenous Immunoglobulin(IVIg) Therapy Market Share by Type 2025 VS 2032 Figure 19. North America Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share in Volume by Type in 2025 Figure 20. North America Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share in Value by Type in 2025 Figure 21. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share in Volume by Type in 2025 Figure 22. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share in Value by Type in 2025 Figure 25. Latin America Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Intravenous Immunoglobulin(IVIg) Therapy Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Autoimmune Disease Image Figure 32. Global Autoimmune Disease Sales YoY Growth (2021-2032) & (K Units) Figure 33. Immunodeficiency Image Figure 34. Global Immunodeficiency Sales YoY Growth (2021-2032) & (K Units) Figure 35. Acute Infection Image Figure 36. Global Acute Infection Sales YoY Growth (2021-2032) & (K Units) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 39. Global Intravenous Immunoglobulin(IVIg) Therapy Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Intravenous Immunoglobulin(IVIg) Therapy Market Share by Application 2025 VS 2032 Figure 41. North America Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share in Volume by Application in 2025 Figure 42. North America Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share in Value by Application in 2025 Figure 43. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share in Volume by Application in 2025 Figure 44. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share in Value by Application in 2025 Figure 47. Latin America Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share in Value by Application in 2025 Figure 51. North America Intravenous Immunoglobulin(IVIg) Therapy Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. North America Intravenous Immunoglobulin(IVIg) Therapy Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Intravenous Immunoglobulin(IVIg) Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Intravenous Immunoglobulin(IVIg) Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Intravenous Immunoglobulin(IVIg) Therapy Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Latin America Intravenous Immunoglobulin(IVIg) Therapy Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Intravenous Immunoglobulin(IVIg) Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 68. Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Intravenous Immunoglobulin(IVIg) Therapy Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Intravenous Immunoglobulin(IVIg) Therapy Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • 5g/100ml
  • 2.5g/50ml
  • 1g/20ml
  • 10g/200ml
  • 1.25g/25ml
  • Others
Applications
  • Autoimmune Disease
  • Immunodeficiency
  • Acute Infection
  • Others
Companies covered
  • TEIJIN LIMITED
  • Baxter
  • Biotest
  • Boya-Bio
  • CNBG
  • CSL Plasma
  • Grifols
  • Kamada
  • Kedrion
  • LFB Group
  • Nanyue Biopharming
  • Octapharma
  • Sinopharm
  • Beijing Tiantan Biological Products
  • Guangdong Shuagnlin Bio-pharmacy
  • Hualan Bio
  • Shanghai RAAS
  • Weiguang Biological
  • Taibang Biologic Group
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Intravenous Immunoglobulin(IVIg) Therapy Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Intravenous Immunoglobulin(IVIg) Therapy Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Intravenous Immunoglobulin(IVIg) Therapy Market by Type
  6. 1.3.1 5g/100ml
  7. 1.3.2 2.5g/50ml
  8. 1.3.3 1g/20ml
  9. 1.3.4 10g/200ml
  10. 1.3.5 1.25g/25ml
  11. 1.3.6 Others
  12. 1.4 Global Intravenous Immunoglobulin(IVIg) Therapy Market Size by Type
  13. 1.4.1 Global Intravenous Immunoglobulin(IVIg) Therapy Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Intravenous Immunoglobulin(IVIg) Therapy Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Intravenous Immunoglobulin(IVIg) Therapy Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Intravenous Immunoglobulin(IVIg) Therapy Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Intravenous Immunoglobulin(IVIg) Therapy Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Intravenous Immunoglobulin(IVIg) Therapy Industry Trends
  2. 2.2 Intravenous Immunoglobulin(IVIg) Therapy Industry Drivers
  3. 2.3 Intravenous Immunoglobulin(IVIg) Therapy Industry Opportunities and Challenges
  4. 2.4 Intravenous Immunoglobulin(IVIg) Therapy Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Intravenous Immunoglobulin(IVIg) Therapy Revenue (2021-2026)
  2. 3.2 Global Top Players by Intravenous Immunoglobulin(IVIg) Therapy Sales (2021-2026)
  3. 3.3 Global Top Players by Intravenous Immunoglobulin(IVIg) Therapy Price (2021-2026)
  4. 3.4 Global Intravenous Immunoglobulin(IVIg) Therapy Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Intravenous Immunoglobulin(IVIg) Therapy Major Company Production Sites & Headquarters
  6. 3.6 Global Intravenous Immunoglobulin(IVIg) Therapy Company, Product Type & Application
  7. 3.7 Global Intravenous Immunoglobulin(IVIg) Therapy Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Intravenous Immunoglobulin(IVIg) Therapy Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Intravenous Immunoglobulin(IVIg) Therapy Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Intravenous Immunoglobulin(IVIg) Therapy Tier 1, Tier 2, and Tier 3
4 Intravenous Immunoglobulin(IVIg) Therapy Regional Status and Outlook
  1. 4.1 Global Intravenous Immunoglobulin(IVIg) Therapy Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Intravenous Immunoglobulin(IVIg) Therapy Historic Market Size by Region
  3. 4.2.1 Global Intravenous Immunoglobulin(IVIg) Therapy Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Intravenous Immunoglobulin(IVIg) Therapy Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Intravenous Immunoglobulin(IVIg) Therapy Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Intravenous Immunoglobulin(IVIg) Therapy Forecasted Market Size by Region
  7. 4.3.1 Global Intravenous Immunoglobulin(IVIg) Therapy Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Intravenous Immunoglobulin(IVIg) Therapy Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Intravenous Immunoglobulin(IVIg) Therapy Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Intravenous Immunoglobulin(IVIg) Therapy by Application
  1. 5.1 Intravenous Immunoglobulin(IVIg) Therapy Market by Application
  2. 5.1.1 Autoimmune Disease
  3. 5.1.2 Immunodeficiency
  4. 5.1.3 Acute Infection
  5. 5.1.4 Others
  6. 5.2 Global Intravenous Immunoglobulin(IVIg) Therapy Market Size by Application
  7. 5.2.1 Global Intravenous Immunoglobulin(IVIg) Therapy Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Intravenous Immunoglobulin(IVIg) Therapy Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Intravenous Immunoglobulin(IVIg) Therapy Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Intravenous Immunoglobulin(IVIg) Therapy Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Intravenous Immunoglobulin(IVIg) Therapy Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 TEIJIN LIMITED
  2. 6.1.1 TEIJIN LIMITED Company Information
  3. 6.1.2 TEIJIN LIMITED Business Overview
  4. 6.1.3 TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  6. 6.1.5 TEIJIN LIMITED Recent Developments
  7. 6.2 Baxter
  8. 6.2.1 Baxter Company Information
  9. 6.2.2 Baxter Business Overview
  10. 6.2.3 Baxter Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Baxter Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  12. 6.2.5 Baxter Recent Developments
  13. 6.3 Biotest
  14. 6.3.1 Biotest Company Information
  15. 6.3.2 Biotest Business Overview
  16. 6.3.3 Biotest Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Biotest Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  18. 6.3.5 Biotest Recent Developments
  19. 6.4 Boya-Bio
  20. 6.4.1 Boya-Bio Company Information
  21. 6.4.2 Boya-Bio Business Overview
  22. 6.4.3 Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  24. 6.4.5 Boya-Bio Recent Developments
  25. 6.5 CNBG
  26. 6.5.1 CNBG Company Information
  27. 6.5.2 CNBG Business Overview
  28. 6.5.3 CNBG Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 CNBG Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  30. 6.5.5 CNBG Recent Developments
  31. 6.6 CSL Plasma
  32. 6.6.1 CSL Plasma Company Information
  33. 6.6.2 CSL Plasma Business Overview
  34. 6.6.3 CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  36. 6.6.5 CSL Plasma Recent Developments
  37. 6.7 Grifols
  38. 6.7.1 Grifols Company Information
  39. 6.7.2 Grifols Business Overview
  40. 6.7.3 Grifols Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Grifols Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  42. 6.7.5 Grifols Recent Developments
  43. 6.8 Kamada
  44. 6.8.1 Kamada Company Information
  45. 6.8.2 Kamada Business Overview
  46. 6.8.3 Kamada Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Kamada Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  48. 6.8.5 Kamada Recent Developments
  49. 6.9 Kedrion
  50. 6.9.1 Kedrion Company Information
  51. 6.9.2 Kedrion Business Overview
  52. 6.9.3 Kedrion Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Kedrion Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  54. 6.9.5 Kedrion Recent Developments
  55. 6.10 LFB Group
  56. 6.10.1 LFB Group Company Information
  57. 6.10.2 LFB Group Business Overview
  58. 6.10.3 LFB Group Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 LFB Group Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  60. 6.10.5 LFB Group Recent Developments
  61. 6.11 Nanyue Biopharming
  62. 6.11.1 Nanyue Biopharming Company Information
  63. 6.11.2 Nanyue Biopharming Business Overview
  64. 6.11.3 Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  66. 6.11.5 Nanyue Biopharming Recent Developments
  67. 6.12 Octapharma
  68. 6.12.1 Octapharma Company Information
  69. 6.12.2 Octapharma Business Overview
  70. 6.12.3 Octapharma Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Octapharma Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  72. 6.12.5 Octapharma Recent Developments
  73. 6.13 Sinopharm
  74. 6.13.1 Sinopharm Company Information
  75. 6.13.2 Sinopharm Business Overview
  76. 6.13.3 Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  78. 6.13.5 Sinopharm Recent Developments
  79. 6.14 Beijing Tiantan Biological Products
  80. 6.14.1 Beijing Tiantan Biological Products Company Information
  81. 6.14.2 Beijing Tiantan Biological Products Business Overview
  82. 6.14.3 Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  84. 6.14.5 Beijing Tiantan Biological Products Recent Developments
  85. 6.15 Guangdong Shuagnlin Bio-pharmacy
  86. 6.15.1 Guangdong Shuagnlin Bio-pharmacy Company Information
  87. 6.15.2 Guangdong Shuagnlin Bio-pharmacy Business Overview
  88. 6.15.3 Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  90. 6.15.5 Guangdong Shuagnlin Bio-pharmacy Recent Developments
  91. 6.16 Hualan Bio
  92. 6.16.1 Hualan Bio Company Information
  93. 6.16.2 Hualan Bio Business Overview
  94. 6.16.3 Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  96. 6.16.5 Hualan Bio Recent Developments
  97. 6.17 Shanghai RAAS
  98. 6.17.1 Shanghai RAAS Company Information
  99. 6.17.2 Shanghai RAAS Business Overview
  100. 6.17.3 Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  102. 6.17.5 Shanghai RAAS Recent Developments
  103. 6.18 Weiguang Biological
  104. 6.18.1 Weiguang Biological Company Information
  105. 6.18.2 Weiguang Biological Business Overview
  106. 6.18.3 Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  108. 6.18.5 Weiguang Biological Recent Developments
  109. 6.19 Taibang Biologic Group
  110. 6.19.1 Taibang Biologic Group Company Information
  111. 6.19.2 Taibang Biologic Group Business Overview
  112. 6.19.3 Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  114. 6.19.5 Taibang Biologic Group Recent Developments
  115. 6.20 Takeda
  116. 6.20.1 Takeda Company Information
  117. 6.20.2 Takeda Business Overview
  118. 6.20.3 Takeda Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Takeda Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
  120. 6.20.5 Takeda Recent Developments
7 North America by Country
  1. 7.1 North America Intravenous Immunoglobulin(IVIg) Therapy Sales by Country
  2. 7.1.1 North America Intravenous Immunoglobulin(IVIg) Therapy Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2021-2026)
  4. 7.1.3 North America Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Country (2027-2032)
  5. 7.2 North America Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country
  6. 7.2.1 North America Intravenous Immunoglobulin(IVIg) Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country (2021-2026)
  8. 7.2.3 North America Intravenous Immunoglobulin(IVIg) Therapy Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Country
  2. 8.1.1 Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2021-2026)
  4. 8.1.3 Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country
  6. 8.2.1 Europe Intravenous Immunoglobulin(IVIg) Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country (2021-2026)
  8. 8.2.3 Europe Intravenous Immunoglobulin(IVIg) Therapy Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales by Country
  2. 9.1.1 Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country
  6. 9.2.1 Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Intravenous Immunoglobulin(IVIg) Therapy Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Intravenous Immunoglobulin(IVIg) Therapy Sales by Country
  2. 10.1.1 South America Intravenous Immunoglobulin(IVIg) Therapy Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2021-2026)
  4. 10.1.3 South America Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Country (2027-2032)
  5. 10.2 South America Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country
  6. 10.2.1 South America Intravenous Immunoglobulin(IVIg) Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country (2021-2026)
  8. 10.2.3 South America Intravenous Immunoglobulin(IVIg) Therapy Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Country
  2. 11.1.1 Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country
  6. 11.2.1 Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Intravenous Immunoglobulin(IVIg) Therapy Value Chain Analysis
  2. 12.1.1 Intravenous Immunoglobulin(IVIg) Therapy Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Intravenous Immunoglobulin(IVIg) Therapy Production Mode & Process
  7. 12.2 Intravenous Immunoglobulin(IVIg) Therapy Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Intravenous Immunoglobulin(IVIg) Therapy Distributors
  10. 12.2.3 Intravenous Immunoglobulin(IVIg) Therapy Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst